Please assess the completion status of the following clinical trial:

Trial Title: Study Evaluating the Effects of Toradol and Lyrica for Pain Control After Donor Nephrectomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients anticipating donating a kidney in a live kidney donor transplant.~Exclusion Criteria:~* Patients not receiving a donor nephrectomy~* Pregnant, lactating, or nursing mothers~* Medical allergies or history that would otherwise be contraindicated for of a non-steroidal anti-inflammatory drug.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Toradol and Lyrica (Type: EXPERIMENTAL): Over-Encapsulated Pregabalin 75 mg was administered PO 30 minutes prior to operation; Ketorolac 30 mg IV x 1 was administered in the OR, followed by ketorolac 15 mg IV every 6 hours for 7 doses (or until discharge).
- Placebo and Standard of Care (Type: PLACEBO_COMPARATOR): Identical placebo oral capsule (same size and color) was administered PO 30 minutes prior to operation; Saline placebo IV x 1 was administered in the OR, followed by saline placebo IV every 6 hours for 7 doses. Standard of care practices maintained.

Based on this trial design, predict the completion outcome and termination type (if applicable).